Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment
Annals of Clinical and Translational Neurology2018Vol. 5(5), pp. 616–629
Citations Over TimeTop 19% of 2018 papers
Yonatan A. Cooper, Daniel Nachun, Deepika Dokuru, Zhongan Yang, Anna M. Karydas, Ginette Serrero, Binbin Yue, Alzheimer's Disease Neuroimaging Initiative, Adam L. Boxer, Bruce L. Miller, Giovanni Coppola
Abstract
Progranulin mRNA is elevated in peripheral blood of patients with AD and MCI and its expression is associated with numerous genetic and demographic factors. These data suggest a role in the pathogenesis of neurodegenerative dementias besides frontotemporal dementia.
Related Papers
- → Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid(2016)71 cited
- → APOE Genotype Results in Differential Effects on the Peripheral Clearance of Amyloid-β42 in APOE Knock-in and Knock-out Mice(2010)55 cited
- → APOE ε3/ε4 and APOE ε4/ε4 genotypes drive unique gene signatures in the cortex of young mice(2020)3 cited
- → The Expression of Apolipoprotein E in Osteoblastic Cells on Titanium(2009)
- → [P3–106]: CHASING THE CAUSE OF PLASMA APOE DEFICIENCY IN THE LIVERS OF APOEε4 CARRIERS(2017)